Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Series A round brings Annovation Biopharma $8mm

Executive Summary

Existing shareholders Atlas Venture and Partners Innovation Fund (PIF), plus new backer The Medicines Co. (TMC), have led an $8mm Series A financing for Annovation Biopharma Inc. (anesthetics and critical care medicines). The round may be expanded to $11mm. Atlas Venture Development Corp. managing director David Grayzel, MD, has joined as executive chairman of the board, and Atlas, PIF, and TMC have contributed board members.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies